Assembling an understanding of ribosome biosynthesis

加深对核糖体生物合成的理解

• 批准号: 9001340
• 负责人: Gloria M Culver
• 金额: $ 34.54万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-03-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9001340
• 关键词: Accounting; Affect; Affinity; Affinity Chromatography; Anabolism; Antibiotics; Bacteria; Bacterial Drug Resistance; Benchmarking; Beryllium; Binding; Biochemistry; Biogenesis; Cell physiology; Cells; Characteristics; Chemicals; Complement; Complex; Coupling; Data; Development; Elements; Escherichia coli; Event; Evolution; Foundations; Future; Genes; Genetic; Goals; Growth; Health; Human; Indium; Knowledge; Lead; Lesion; Light; Link; Location; MS2 coat protein; Medical; Methodology; Methods; Modification; Molecular Biology; Multi-Drug Resistance; Organism; Pathogenicity; Pathway interactions; Population; Positioning Attribute; Process; Proteins; Proteomics; RNA-Protein Interaction; Recombinant DNA; Ribonucleoproteins; Ribosomal RNA; Ribosomes; Role; Staging; Structure; System; Transcription Process; Translation Initiation; Translation Process; Translations; Work; antimicrobial; computerized data processing; drug resistant bacteria; in vivo; insight; novel; particle; pathogenic bacteria; rRNA Precursor; screening

DESCRIPTION (provided by applicant): The fundamental and essential process of translation is catalyzed by the ribosome, and this proposal focuses on biogenesis of the ribosome. Ribosomes are intricate RNPs, whose biogenesis involves the transcription, processing, modification and folding of rRNA and the dynamic binding of r-proteins and at least 40 assembly factors. Ribosomes have long been the benchmark for understanding functional capabilities of complex RNPs, and work to unravel the mechanisms of 30S subunit biogenesis will similarly increase our understanding of biogenesis of all cellular RNPs. Our long-term goal is to gain a detailed understanding of the factors and pathways involved in E. coli ribosomal subunit biogenesis. Since bacterial and eukaryotic ribosome biogenesis share several features, results from these studies will undoubtedly lead to new conserved features and new insights into biogenesis of eukaryotic ribosomes. Furthermore, since ribosome biogenesis is likely to be highly conserved among bacteria and is linked to pathogenicity of some bacteria, discoveries of bacterial- specific biogenesis events will yield a number of new possible antimicrobial targets and likely new insights into possible methodologies for medical manipulation to alter growth of pathogenic bacteria. Our approach involves the isolation of in vivo formed intermediates and subsequent analysis of the components, structures, and processing of these particles. Preliminary results have shown the existence of three distinct complexes, at least 30 potential assembly factors, three of which we have already confirmed as assembly factors. We will use these data to further interrogate ribosome biogenesis and to identify important steps in this process. We will use biochemistry, genetics, molecular biology and proteomics to study ribosomal subunit biogenesis intermediates and factors that are involved in these processes and these data will be used to develop a network of interactions important for this process in bacteria. These studies will not only result in novel targets for antibiotic screening and insights into bacterial drug resistance, but will also yield better understanding of the evolution of ribosome biogenesis, and the interplay of biogenesis with fundamental aspects of cell physiology.

描述（由申请人提供）：翻译的基本和必要过程是由核糖体催化的，并且该提议集中于核糖体的生物发生。核糖体是一种复杂的核糖体，其生物发生涉及rRNA的转录、加工、修饰和折叠以及r蛋白和至少40种组装因子的动态结合。核糖体长期以来一直是理解复杂RNP功能能力的基准，解开30S亚基生物合成机制的工作将同样增加我们对所有细胞RNP生物合成的理解。 我们的长期目标是详细了解E.大肠杆菌核糖体亚基生物发生。由于细菌和真核生物核糖体的生物发生有几个共同的特点，这些研究的结果无疑将导致新的保守功能和新的见解真核生物核糖体的生物发生。此外，由于核糖体生物发生在细菌中可能是高度保守的，并且与一些细菌的致病性相关，因此细菌特异性生物发生事件的发现将产生许多新的可能的抗微生物靶标，并且可能对用于改变致病性细菌生长的医学操纵的可能方法学产生新的见解。 我们的方法包括分离体内形成的中间体，并随后分析这些颗粒的成分、结构和加工。初步结果表明，存在三种不同的复合物，至少有30个潜在的组装因子，其中三个我们已经确认为组装因子。我们将使用这些数据来进一步询问核糖体的生物合成，并确定这一过程中的重要步骤。我们将使用生物化学，遗传学，分子生物学和蛋白质组学来研究参与这些过程的核糖体亚基生物合成中间体和因子，这些数据将用于开发对细菌中这一过程重要的相互作用网络。这些研究不仅将为抗生素筛选和见解带来新的靶点， 细菌耐药性，但也将产生更好的理解核糖体生物合成的进化，以及生物合成与细胞生理学基本方面的相互作用。